• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Migration (4003)
Patient Problem Therapeutic Response, Decreased (2271)
Event Date 09/03/2019
Event Type  Injury  
Manufacturer Narrative
The devices have not been returned; the reported events could not be confirmed.The causes of the events could not be conclusively determined from the reported information.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Shields, l.B., shields, c.B., ghiassi, m., dashti, s.R., yao, t.L., zhang, y.P., & ghiassi, m.(2019).Pipeline embolization device for treatment of craniocervical internal carotid artery dissections: report of 3 cases.World neurosurgery, 132, 106¿112.Doi: 10.1016/j.Wneu.2019.08.183 medtronic literature review found a report of retreatment after pipeline (ped) implantation.A patient presented with pre-existing headache and ipsilateral partial horner's syndrome due to dissection of the distal left internal carotid artery.The patient underwent endovascular treatment in which four telescoping peds were implanted to reconstruct the left ica dissection from the petrous down to its origin in the cervical segment to create adequate flow diversion.Postoperatively, the patient had complete resolution of his headache and horner¿s syndrome and was discharged on aspirin and clopidogrel.Five months post-procedure, dsa demonstrated excellent revascularization; however, a separation of the 2 peds was identified at the skull base, along with evidence of a small residual pseudoaneurysm at the space between the peds.An additional ped (5 x 35 mm) overlapping the gap was placed, resulting in good flow diversion.At 4 months after the second procedure, repeat angiography revealed normal vessel caliber and flow with complete endothelialization of the peds.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE FLEX EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
melody roppel
1000 colonel anderson pkwy
irvine, CA 92618
9496801345
MDR Report Key9919055
MDR Text Key195547034
Report Number2029214-2020-00324
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100018.S011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 04/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/10/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age35 YR
Patient Weight84
-
-